Rainmed Medical Ltd
02297
Company Profile
Business description
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company’s core products, the caFFR system and the caIMR system are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
Contact
No. 99, Jinji Lake Avenue
Building 31, Northeast District
Suzhou Industrial Park, Jiangsu Province
Suzhou215000
CHNT: +86 51262622215
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
214
Stocks News & Analysis
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,126.90 | 2.50 | -0.03% |
| CAC 40 | 7,721.90 | 22.98 | 0.30% |
| DAX 40 | 23,715.48 | 118.50 | 0.50% |
| Dow JONES (US) | 45,350.50 | 270.79 | -0.59% |
| FTSE 100 | 9,210.37 | 2.16 | 0.02% |
| HKSE | 25,633.91 | 215.93 | 0.85% |
| NASDAQ | 21,810.67 | 102.98 | 0.47% |
| Nikkei 225 | 43,643.81 | 625.06 | 1.45% |
| NZX 50 Index | 13,281.14 | 57.61 | 0.44% |
| S&P 500 | 6,493.45 | 11.95 | 0.18% |
| S&P/ASX 200 | 8,849.60 | 5.60 | -0.06% |
| SSE Composite Index | 3,826.84 | 14.33 | 0.38% |